Cargando…

Long-term survival without graft-versus-host-disease following infusion of allogeneic myeloma-specific Vβ T cell families

BACKGROUND: Despite chemo-induction therapy and autologous stem cell transplantation (ASCT), the vast majority of patients with Multiple Myeloma (MM) relapse within 7 years and the disease remains incurable. Adoptive Allogeneic T-cell therapy (ATCT) might be curative for MM, however current ATCT pro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yado, S., Luboshits, G., Hazan, O., Or, R., Firer, M. A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6854718/ https://www.ncbi.nlm.nih.gov/pubmed/31727148 http://dx.doi.org/10.1186/s40425-019-0776-9

Ejemplares similares

The Impact of Induction Regimes on Immune Responses in Patients with Multiple Myeloma
por: Firer, Michael A., et al.
Publicado: (2021)

Effect of acute and chronic graft-versus-host disease on relapse and survival after reduced-intensity conditioning allogeneic transplantation for myeloma
por: Ringdén, Olle, et al.
Publicado: (2011)

High‐density lipoprotein infusion protects from acute graft‐versus‐host disease in experimental allogeneic hematopoietic cell transplantation
por: Chagué, Cécile, et al.
Publicado: (2022)

EPC infusion ameliorates acute graft-versus-host disease-related endothelial injury after allogeneic bone marrow transplantation
por: Wang, Weiwei, et al.
Publicado: (2022)

Graft-versus-host disease in allogeneic transplantation: the good and the bad
por: Kröger, Nicolaus-Martin
Publicado: (2022)

Transplantation of allogeneic bone marrow without graft-versus-host disease using total lymphoid irradiation
Publicado: (1978)

Apoptosis of ileal crypt epithelia after allogeneic bone marrow transplantation without graft-versus-host disease
por: Kreft, Andreas, et al.
Publicado: (2015)

Allogeneic hematopoietic cell transplantation, the microbiome, and graft-versus-host disease
por: van Lier, Yannouck F., et al.
Publicado: (2023)

The graft-versus-leukemia effect of prophylactic donor lymphocyte infusions after allogeneic stem cell transplantation is equally effective in relapse prevention but safer compared to spontaneous graft-versus-host disease
por: Stadler, Michael, et al.
Publicado: (2023)

Establishment of a Murine Graft-versus-Myeloma Model Using Allogeneic Stem Cell Transplantation
por: Binsfeld, Marilène, et al.
Publicado: (2014)

THE FACTOR OF IMMUNIZATION IN THE RAT : THE EFFECT OF ALLOGENEIC IMMUNIZATION ON GRAFT-VERSUS-HOST ACTIVITY
por: Ford, William L., et al.
Publicado: (1971)

Mobilized Multipotent Hematopoietic Progenitors Promote Expansion and Survival of Allogeneic Tregs and Protect Against Graft Versus Host Disease
por: D’Aveni, Maud, et al.
Publicado: (2021)

Ocular findings and ocular graft-versus-host disease after allogeneic stem cell transplantation without total body irradiation
por: Pathak, Meeta, et al.
Publicado: (2018)

Combination of anti‐CD4 antibody treatment and donor lymphocyte infusion ameliorates graft‐versus‐host disease while preserving graft‐versus‐tumor effects in murine allogeneic hematopoietic stem cell transplantation
por: Ueha, Satoshi, et al.
Publicado: (2017)

Correction: Establishment of a Murine Graft-versus-Myeloma Model Using Allogeneic Stem Cell Transplantation
Publicado: (2015)

Gastric and small bowel perforations secondary to mucormycosis and graft versus host disease in an allogeneic transplant host
por: Ibrahim, Uroosa, et al.
Publicado: (2021)

Predictors of recovery following allogeneic CD34+-selected cell infusion without conditioning to correct poor graft function
por: Cuadrado, Maria M., et al.
Publicado: (2019)

Durable Remission of Renal Cell Carcinoma in Conjuncture with Graft versus Host Disease following Allogeneic Stem Cell Transplantation and Donor Lymphocyte Infusion: Rule or Exception?
por: van Bergen, Cornelis A. M., et al.
Publicado: (2014)

Chronic kidney disease, survival and graft-versus-host-disease-free/relapse-free survival in recipients of allogeneic hematopoietic stem cell transplant
por: Pelletier, Karyne, et al.
Publicado: (2022)

The Role of Pattern-Recognition Receptors in Graft-Versus-Host Disease and Graft-Versus-Leukemia after Allogeneic Stem Cell Transplantation
por: Heidegger, Simon, et al.
Publicado: (2014)

Acute Graft-Versus-Host Disease of the Kidney in Allogeneic Rat Bone Marrow Transplantation
por: Higo, Seiichiro, et al.
Publicado: (2014)

Interleukin-22 in Graft-Versus-Host Disease after Allogeneic Stem Cell Transplantation
por: Lamarthée, Baptiste, et al.
Publicado: (2016)

Purinergic Signalling in Allogeneic Haematopoietic Stem Cell Transplantation and Graft-versus-Host Disease
por: Cuthbertson, Peter, et al.
Publicado: (2021)

Prolonged Survival of Subcutaneous Allogeneic Islet Graft by Donor Chimerism without Immunosuppressive Treatment
por: Hsu, Brend Ray-Sea, et al.
Publicado: (2017)

Graft Cryopreservation Does Not Impact Overall Survival after Allogeneic Hematopoietic Cell Transplantation Using Post-Transplantation Cyclophosphamide for Graft-versus-Host Disease Prophylaxis
por: Hamadani, Mehdi, et al.
Publicado: (2020)

Gold nanoparticles stabilize peptide-drug-conjugates for sustained targeted drug delivery to cancer cells
por: Kalimuthu, Kalishwaralal, et al.
Publicado: (2018)

Autologous Graft versus Host Disease: An Emerging Complication in Patients with Multiple Myeloma
por: Batra, Anu, et al.
Publicado: (2014)

Prognostic Factors on the Graft-versus-Host Disease-Free and Relapse-Free Survival after Adult Allogeneic Hematopoietic Stem Cell Transplantation
por: Liu, Yao-Chung, et al.
Publicado: (2016)

Graft conditioning with fluticasone propionate reduces graft‐versus‐host disease upon allogeneic hematopoietic cell transplantation in mice
por: Varady, Erika S, et al.
Publicado: (2023)

Immune Reconstitution and Graft-Versus-Host Reactions in Rat Models of Allogeneic Hematopoietic Cell Transplantation
por: Zinöcker, Severin, et al.
Publicado: (2012)

Methotrexate for the Treatment of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation
por: Nassar, Amr, et al.
Publicado: (2014)

Natural Killer Cells in Graft-versus-Host-Disease after Allogeneic Hematopoietic Cell Transplantation
por: Simonetta, Federico, et al.
Publicado: (2017)

Antibiotic Therapy and Gastrointestinal Graft-Versus-Host Disease in the Allogeneic Stem Cell Transplantation Population
por: Thomas, Jessica, et al.
Publicado: (2022)

Innate Immune Determinants of Graft-Versus-Host Disease and Bidirectional Immune Tolerance in Allogeneic Transplantation
por: Hamers, Anouk A. J., et al.
Publicado: (2019)

Ceacam1 Separates Graft-versus-Host-Disease from Graft-versus-Tumor Activity after Experimental Allogeneic Bone Marrow Transplantation
por: Lu, Sydney X., et al.
Publicado: (2011)

Editorial on Translational Research in Graft-Versus-Host Disease (GVHD) and Graft-Versus-Tumor (GVT) Effect After Allogeneic Hematopoietic Cell Transplantation
por: Czech, Marie, et al.
Publicado: (2022)

Microbiota long-term dynamics and prediction of acute graft-versus-host disease in pediatric allogeneic stem cell transplantation
por: Ingham, Anna Cäcilia, et al.
Publicado: (2021)

Muscle Cramps and Neuropathies in Patients with Allogeneic Hematopoietic Stem Cell Transplantation and Graft-versus-Host Disease
por: Kraus, Peter D., et al.
Publicado: (2012)

Acute Renal Graft-Versus-Host Disease in a Murine Model of Allogeneic Bone Marrow Transplantation
por: Schmid, Peter M., et al.
Publicado: (2017)

Myasthenia Gravis Presenting as Graft versus Host Disease after Allogeneic Blood Stem Cell Transplant
por: Ahmed, Zarir, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_isrc4spnulcdaghgbsg0qt5or6